These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
692 related items for PubMed ID: 22488108
1. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma. Tanaka S, Shiraha H, Nakanishi Y, Nishina S, Matsubara M, Horiguchi S, Takaoka N, Iwamuro M, Kataoka J, Kuwaki K, Hagihara H, Toshimori J, Ohnishi H, Takaki A, Nakamura S, Nouso K, Yagi T, Yamamoto K. Int J Cancer; 2012 Dec 01; 131(11):2537-46. PubMed ID: 22488108 [Abstract] [Full Text] [Related]
2. Restored expression of the tumor suppressor gene RUNX3 reduces cancer stem cells in hepatocellular carcinoma by suppressing Jagged1-Notch signaling. Nishina S, Shiraha H, Nakanishi Y, Tanaka S, Matsubara M, Takaoka N, Uemura M, Horiguchi S, Kataoka J, Iwamuro M, Yagi T, Yamamoto K. Oncol Rep; 2011 Sep 01; 26(3):523-31. PubMed ID: 21637926 [Abstract] [Full Text] [Related]
5. Comprehensive analysis of the independent effect of twist and snail in promoting metastasis of hepatocellular carcinoma. Yang MH, Chen CL, Chau GY, Chiou SH, Su CW, Chou TY, Peng WL, Wu JC. Hepatology; 2009 Nov 01; 50(5):1464-74. PubMed ID: 19821482 [Abstract] [Full Text] [Related]
6. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1. Zhao XL, Sun T, Che N, Sun D, Zhao N, Dong XY, Gu Q, Yao Z, Sun BC. J Cell Mol Med; 2011 Mar 01; 15(3):691-700. PubMed ID: 20219012 [Abstract] [Full Text] [Related]
7. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma. Yamada S, Okumura N, Wei L, Fuchs BC, Fujii T, Sugimoto H, Nomoto S, Takeda S, Tanabe KK, Kodera Y. Ann Surg Oncol; 2014 Nov 01; 21(12):3882-90. PubMed ID: 24833103 [Abstract] [Full Text] [Related]
8. Invasion and EMT-associated genes are up-regulated in B viral hepatocellular carcinoma with high expression of CD133-human and cell culture study. Na DC, Lee JE, Yoo JE, Oh BK, Choi GH, Park YN. Exp Mol Pathol; 2011 Feb 01; 90(1):66-73. PubMed ID: 20969862 [Abstract] [Full Text] [Related]
9. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway. Wang YP, Yu GR, Lee MJ, Lee SY, Chu IS, Leem SH, Kim DG. Hepatology; 2013 Oct 01; 58(4):1349-61. PubMed ID: 23696034 [Abstract] [Full Text] [Related]
10. CCR7 preservation via histone deacetylase inhibition promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells. Yang L, Chang Y, Cao P. Exp Cell Res; 2018 Oct 01; 371(1):231-237. PubMed ID: 30107147 [Abstract] [Full Text] [Related]
11. RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition. Song FN, Duan M, Liu LZ, Wang ZC, Shi JY, Yang LX, Zhou J, Fan J, Gao Q, Wang XY. PLoS One; 2014 Oct 01; 9(9):e108507. PubMed ID: 25268581 [Abstract] [Full Text] [Related]
12. Metastasin leads to poor prognosis of hepatocellular carcinoma through partly inducing EMT. Zheng X, Gai X, Wu Z, Liu Q, Yao Y. Oncol Rep; 2013 May 01; 29(5):1811-8. PubMed ID: 23483190 [Abstract] [Full Text] [Related]
13. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells. Zhang C, Guo F, Xu G, Ma J, Shao F. Oncol Rep; 2015 Apr 01; 33(4):1872-82. PubMed ID: 25653024 [Abstract] [Full Text] [Related]
15. miR-153 inhibits epithelial-to-mesenchymal transition in hepatocellular carcinoma by targeting Snail. Xia W, Ma X, Li X, Dong H, Yi J, Zeng W, Yang Z. Oncol Rep; 2015 Aug 01; 34(2):655-62. PubMed ID: 26035427 [Abstract] [Full Text] [Related]
16. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC. Zhao N, Sun H, Sun B, Zhu D, Zhao X, Wang Y, Gu Q, Dong X, Liu F, Zhang Y, Li X. Sci Rep; 2016 Mar 16; 6():23091. PubMed ID: 26980408 [Abstract] [Full Text] [Related]
17. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging. Li Y, Chen G, Yan Y, Fan Q. Eur J Pharmacol; 2019 Oct 05; 860():172589. PubMed ID: 31401158 [Abstract] [Full Text] [Related]
18. Loss of Runt-related transcription factor 3 induces resistance to 5-fluorouracil and cisplatin in hepatocellular carcinoma. Kataoka J, Shiraha H, Horiguchi S, Sawahara H, Uchida D, Nagahara T, Iwamuro M, Morimoto H, Takeuchi Y, Kuwaki K, Onishi H, Nakamura S, Takaki A, Nouso K, Yagi T, Yamamoto K, Okada H. Oncol Rep; 2016 May 05; 35(5):2576-82. PubMed ID: 26985715 [Abstract] [Full Text] [Related]
19. MicroRNA-20a-5p regulates the epithelial-mesenchymal transition of human hepatocellular carcinoma by targeting RUNX3. Wang X, Wei P, Yang L, Liu F, Tong X, Yang X, Su L. Chin Med J (Engl); 2022 Sep 05; 135(17):2089-2097. PubMed ID: 35143426 [Abstract] [Full Text] [Related]
20. Hypoxia promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells via inducing Twist1 expression. Zhang XD, Dong XQ, Xu JL, Chen SC, Sun Z. Eur Rev Med Pharmacol Sci; 2017 Jul 05; 21(13):3061-3068. PubMed ID: 28742200 [Abstract] [Full Text] [Related] Page: [Next] [New Search]